ITK inhibitors in inflammation and immune-mediated disorders

Nisebita Sahu, Avery August

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Abstract

Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcεR-mediated signaling pathways. In T cells, ITK is an important mediator for actin reorganization, activation of PLCγ, mobilization of calcium, and activation of the NFAT transcription factor. ITK plays an important role in the secretion of IL-2, but more critically, also has a pivotal role in the secretion of Th2 cytokines, IL-4, IL-5 and IL-13. As such, ITK has been shown to regulate the development of effective Th2 response during allergic asthma as well as infections by parasitic worms. This ability of ITK to regulate Th2 responses, along with its pattern of expression, has led to the proposal that it would represent an excellent target for Th2-mediated inflammation. We discuss here the possibilities and pitfalls of targeting ITK for inflammatory disorders.

Original languageEnglish (US)
Pages (from-to)690-703
Number of pages14
JournalCurrent Topics in Medicinal Chemistry
Volume9
Issue number8
DOIs
StatePublished - 2009

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Fingerprint Dive into the research topics of 'ITK inhibitors in inflammation and immune-mediated disorders'. Together they form a unique fingerprint.

Cite this